First-hand account of the current state of addiction governance in Europe, utilising a unique dataset of corporate memberships and networks across the EU to document the overall architecture of corporate political activity and the role addictive substance and behaviour-producing industries play in influencing addiction policy in Europe.

Conventional wisdom once held that the demand for addictive substances like cigarettes, alcohol, and drugs was unlike that for any other economic good and, therefore, unresponsive to traditional market forces. Recently, however, researchers from two disparate fields, economics and behavioral psychology, have found that increases in the overall price of an addictive substance can significantly reduce both the number of users and the amounts those users consume. Changes in the "full price" of addictive substances—including monetary value, time outlay, effort to obtain, and potential penalties for illegal use—yield marked variations in behavioral outcomes and demand. The Economic Analysis of Substance Use and Abuse brings these distinctive fields of study together and presents for the first time an integrated assessment of their data and results. Unique and innovative, this multidisciplinary volume will serve as an important resource in the current debates concerning alcohol and drug use and abuse and the impacts of legalizing illicit drugs.

Analyses the impact of addictive drugs (alcohol, nicotine and illegal drugs) and behaviours (gambling) on the health and wellbeing of individuals and societies based on the latest research and within an innovative new conceptual framework

Estimates indicate that as many as 1 in 4 Americans will experience a mental health problem or will misuse alcohol or drugs in their lifetimes. These disorders are among the most highly stigmatized health conditions in the United States, and they remain barriers to full participation in society in areas as basic as education, housing, and employment. Improving the lives of people with mental health and substance abuse disorders has been a priority in the United States for more than 50 years. The Community Mental Health Act of 1963 is considered a major turning point in America's efforts to improve behavioral healthcare. It ushered in an era of optimism and hope and laid the groundwork for the consumer movement and new models of recovery. The consumer movement gave voice to people with mental and substance use disorders and brought their perspectives and experience into national discussions about mental health. However over the same 50-year period, positive change in American public attitudes and beliefs about mental and substance use disorders has lagged behind these advances. Stigma is a complex social phenomenon based on a relationship between an attribute and a stereotype that assigns undesirable labels, qualities, and behaviors to a person with that attribute. Labeled individuals are then socially devalued, which leads to inequality and discrimination. This report contributes to national efforts to understand and change attitudes, beliefs and behaviors that can lead to stigma and discrimination. Changing stigma in a lasting way will require coordinated efforts, which are based on the best possible evidence, supported at the national level with multiyear funding, and planned and implemented by an effective coalition of representative stakeholders. Ending Discrimination Against People with Mental and Substance Use Disorders: The Evidence for Stigma Change explores stigma and discrimination faced by individuals with mental or substance use disorders and recommends effective strategies for reducing stigma and encouraging people to seek treatment and other supportive services. It offers a set of conclusions and recommendations about successful stigma change strategies and the research needed to inform and evaluate these efforts in the United States.

“A mind-blowing tour de force that unwraps the myriad objects of addiction that surround us...Intelligent, incisive, and sometimes grimly entertaining.” —Rod Phillips, author of Alcohol: A History “A fascinating history of corporate America’s efforts to shape our habits and desires.” —Vox We live in an age of addiction, from compulsive gaming and shopping to binge eating and opioid abuse. Sugar can be as habit-forming as cocaine, researchers tell us, and social media apps are deliberately hooking our kids. But what can we do to resist temptations that insidiously rewire our brains? A renowned expert on addiction, David Courtwright reveals how global enterprises have both created and catered to our addictions. The Age of Addiction chronicles the triumph of what he calls “limbic capitalism,” the growing network of competitive businesses targeting the brain pathways responsible for feeling, motivation, and long-term memory. “Compulsively readable...In crisp and playful prose and with plenty of needed humor, Courtwright has written a fascinating history of what we like and why we like it, from the first taste of beer in the ancient Middle East to opioids in West Virginia.” —American Conservative “A sweeping, ambitious account of the evolution of addiction...This bold, thought-provoking synthesis will appeal to fans of ‘big history’ in the tradition of Guns, Germs, and Steel.” —Publishers Weekly

Impact of Addictive Substances and Behaviours on Individual and Societal Well-being outlines an innovative and fascinating new framework for understanding the harm that addictive substances and behaviours can cause. Taking a holistic approach and with well-being as a central tenet, it demonstrates how using different methods can lead to a more just and evidence-based approach to dealing with addictions. Presenting the latest and most comprehensive research, the expert team of authors examines the harm caused by addictive substances and behaviour, factors that contribute to addictions, and current European approaches to governing addictive substances and behaviours. It is both legal and illegal drugs, and behaviour that cause harm. For the world as a whole, cigarettes were the second largest cause of ill health and early death in 2010, alcohol the fifth, and illegal drugs the eighteenth. Regular and sustained heavy engagement in addictive substances and behaviour also impacts on quality of life and material living conditions. The well-being framework outlined here for understanding this impact places particular emphasis on the reciprocal relationship between well-being and drug use: well-being can be a driver of the heavy use of addictive substances and behaviours, and also compounds the harm done. Furthermore, the response of society can increase the harm caused by drug use, and stigma, social exclusion, and the actions of the criminal justice system can impair individual and societal well-being considerably. Impact of Addictive Substances and Behaviours on Individual and Societal Well-being is based on the research from ALICE RAP, a multidisciplinary European study of addictive substances and behaviours in contemporary society. A timely addition to the field, this book is essential reading for those wanting to make a real impact in the field of addiction prevention policy, including public managers, practitioners, public health professionals, and stakeholders influencing policy for addictive substances and behaviours, as well as academics.

Treating Drug Problems, Volume 2 presents a wealth of incisive and accessible information on the issue of drug abuse and treatment in America. Several papers lay bare the relationship between drug treatment and other aspects of drug policy, including a powerful overview of twentieth century narcotics use in America and a unique account of how the federal government has built and managed the drug treatment system from the 1960s to the present. Two papers focus on the criminal justice system. The remaining papers focus on Employer policies and practices toward illegal drugs. Patterns and cycles of cocaine use in subcultures and the popular culture. Drug treatment from a marketing, supply-and-demand perspective, including an analysis of policy options. Treating Drug Problems, Volume 2 provides important information to policy makers and administrators, drug treatment specialists, and researchers.